标题
Synthetic self-adjuvanting glycopeptide cancer vaccines
作者
关键词
-
出版物
Frontiers in Chemistry
Volume 3, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2015-10-24
DOI
10.3389/fchem.2015.00060
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antibody Induction Directed against the Tumor-Associated MUC4 Glycoprotein
- (2015) Hui Cai et al. CHEMBIOCHEM
- Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide
- (2015) Pamela Thompson et al. CHEMICAL COMMUNICATIONS
- Synthetic Multivalent Glycopeptide-Lipopeptide Antitumor Vaccines: Impact of the Cluster Effect on the Killing of Tumor Cells
- (2014) Hui Cai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Immune and Anticancer Responses Elicited by Fully Synthetic Aberrantly Glycosylated MUC1 Tripartite Vaccines Modified by a TLR2 or TLR9 Agonist
- (2014) Abu-Baker M. Abdel-Aal et al. CHEMBIOCHEM
- Synthesis and immunological evaluation of self-adjuvanting MUC1-macrophage activating lipopeptide 2 conjugate vaccine candidates
- (2014) David M. McDonald et al. CHEMICAL COMMUNICATIONS
- Synthesis and Characterisation of Self-Assembled and Self-Adjuvanting Asymmetric Multi-Epitope Lipopeptides of Ovalbumin
- (2014) Sharareh Eskandari et al. CHEMISTRY-A EUROPEAN JOURNAL
- The use of a TLR2 agonist-based adjuvant for enhancing effector and memory CD8 T-cell responses
- (2014) Brendon Y Chua et al. IMMUNOLOGY AND CELL BIOLOGY
- A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy
- (2014) Regan J Anderson et al. Nature Chemical Biology
- Synthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriers
- (2014) Zhifang Zhou et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- A quantitative and site-specific chemoenzymatic glycosylation approach for PEGylated MUC1 peptides
- (2014) Claudia Bello et al. Chemical Science
- Self-Adjuvanting Polymer–Peptide Conjugates As Therapeutic Vaccine Candidates against Cervical Cancer
- (2013) Tzu-Yu Liu et al. BIOMACROMOLECULES
- The development of synthetic antitumour vaccines from mucin glycopeptide antigens
- (2013) Nikola Gaidzik et al. CHEMICAL SOCIETY REVIEWS
- A Vision for Vaccines Built from Fully Synthetic Tumor-Associated Antigens: From the Laboratory to the Clinic
- (2013) Rebecca M. Wilson et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Stereoselective Synthesis of Sialylated Tumor-Associated Glycosylamino Acids
- (2013) Leo Corcilius et al. ORGANIC LETTERS
- MUC1 and metastatic cancer
- (2013) Teresa M. Horm et al. Cell Adhesion & Migration
- Harnessing the Power of the Immune System to Target Cancer
- (2012) Gregory Lizée et al. Annual Review of Medicine
- Synthesis and Immunological Evaluation of Self-Assembling and Self-Adjuvanting Tricomponent Glycopeptide Cancer-Vaccine Candidates
- (2012) Brendan L. Wilkinson et al. CHEMISTRY-A EUROPEAN JOURNAL
- Fully Synthetic Self-Adjuvanting Thioether-Conjugated GlycopeptideLipopeptide Antitumor Vaccines for the Induction of Complement-Dependent Cytotoxicity against Tumor Cells
- (2012) Hui Cai et al. CHEMISTRY-A EUROPEAN JOURNAL
- Mucin-based Targeted Pancreatic Cancer Therapy
- (2012) Maria P. Torres et al. CURRENT PHARMACEUTICAL DESIGN
- MUC1 immunotherapy is here to stay
- (2012) Takashi Kimura et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Design of Fully Synthetic, Self-Adjuvanting Vaccine Incorporating the Tumor-Associated Carbohydrate Tn Antigen and Lipoamino Acid-Based Toll-like Receptor 2 Ligand
- (2012) Abu-Baker M. Abdel-Aal et al. JOURNAL OF MEDICINAL CHEMISTRY
- a Totally Synthetic, Self-Assembling, Adjuvant-Free MUC1 Glycopeptide Vaccine for Cancer Therapy
- (2012) Zhi-Hua Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Carbohydrate-Monophosphoryl Lipid A Conjugates Are Fully Synthetic Self-Adjuvanting Cancer Vaccines Eliciting Robust Immune Responses in the Mouse
- (2011) Qianli Wang et al. ACS Chemical Biology
- Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer
- (2011) Brendan L. Wilkinson et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The Present and Future of Peptide Vaccines for Cancer
- (2011) Craig L. Slingluff CANCER JOURNAL
- Synthesis of Tn/T Antigen MUC1 Glycopeptide BSA Conjugates and Their Evaluation as Vaccines
- (2011) Hui Cai et al. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
- Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
- (2011) V. Lakshminarayanan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fully Synthetic Vaccines Consisting of Tumor-Associated MUC1 Glycopeptides and a Lipopeptide Ligand of the Toll-like Receptor 2
- (2010) Anton Kaiser et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synthesis of MUC1–lipopeptide chimeras
- (2010) Brendan L. Wilkinson et al. CHEMICAL COMMUNICATIONS
- Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses
- (2010) Moses O Oyewumi et al. Expert Review of Vaccines
- Linear and Branched Glyco-Lipopeptide Vaccines Follow Distinct Cross-Presentation Pathways and Generate Different Magnitudes of Antitumor Immunity
- (2010) Olivier Renaudet et al. PLoS One
- A Synthetic Vaccine Consisting of a Tumor-Associated Sialyl-TN-MUC1 Tandem-Repeat Glycopeptide and Tetanus Toxoid: Induction of a Strong and Highly Selective Immune Response
- (2009) Anton Kaiser et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Recent advances in multivalent self adjuvanting glycolipopeptide vaccine strategies against breast cancer
- (2009) Aziz Alami Chentoufi et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Biologics through Chemistry: Total Synthesis of a Proposed Dual-Acting Vaccine Targeting Ovarian Cancer by Orchestration of Oligosaccharide and Polypeptide Domains
- (2009) Jianglong Zhu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes
- (2008) Ilham Bettahi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Self-Adjuvanting Lipopeptide Vaccines
- (2008) Peter Moyle et al. CURRENT MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started